203 related articles for article (PubMed ID: 23490298)
1. The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling.
Deatrick KB; Luke CE; Elfline MA; Sood V; Baldwin J; Upchurch GR; Jaffer FA; Wakefield TW; Henke PK
J Vasc Surg; 2013 Nov; 58(5):1375-1384.e2. PubMed ID: 23490298
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT.
Deatrick KB; Obi A; Luke CE; Elfline MA; Sood V; Upchurch GR; Jaffer F; Wakefield TW; Henke PK
Thromb Res; 2013 Sep; 132(3):360-6. PubMed ID: 23978304
[TBL] [Abstract][Full Text] [Related]
3. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.
Sood V; Luke CE; Deatrick KB; Baldwin J; Miller EM; Elfline M; Upchurch GR; Wakefield TW; Henke PK
Thromb Haemost; 2010 Dec; 104(6):1174-83. PubMed ID: 20886179
[TBL] [Abstract][Full Text] [Related]
4. Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.
Sood V; Luke C; Miller E; Mitsuya M; Upchurch GR; Wakefield TW; Myers DD; Henke PK
Ann Vasc Surg; 2010 Feb; 24(2):233-41. PubMed ID: 20142002
[TBL] [Abstract][Full Text] [Related]
5. Deletion of cysteine-cysteine receptor 7 promotes fibrotic injury in experimental post-thrombotic vein wall remodeling.
Laser A; Elfline M; Luke C; Slack D; Shah A; Sood V; Deatrick B; McEvoy B; Ostra C; Comerota A; Kunkel S; Hogaboam C; Henke PK
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):377-85. PubMed ID: 24311382
[TBL] [Abstract][Full Text] [Related]
6. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK
J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119
[TBL] [Abstract][Full Text] [Related]
7. Pre-Clinical Model to Study Recurrent Venous Thrombosis in the Inferior Vena Cava.
Andraska EA; Luke CE; Elfline MA; Henke SP; Madapoosi SS; Metz AK; Hoinville ME; Wakefield TW; Henke PK; Diaz JA
Thromb Haemost; 2018 Jun; 118(6):1048-1057. PubMed ID: 29695021
[TBL] [Abstract][Full Text] [Related]
8. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the TNF-α (Tumor Necrosis Factor-α)-TNF-Rp55 (Tumor Necrosis Factor Receptor p55) Axis in the Resolution of Venous Thrombus.
Nosaka M; Ishida Y; Kimura A; Kuninaka Y; Taruya A; Furuta M; Mukaida N; Kondo T
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2638-2650. PubMed ID: 30354252
[TBL] [Abstract][Full Text] [Related]
10. Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.
Moaveni DK; Lynch EM; Luke C; Sood V; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2008 Mar; 47(3):616-24. PubMed ID: 18295113
[TBL] [Abstract][Full Text] [Related]
11. Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.
Diaz JA; Ballard-Lipka NE; Farris DM; Hawley AE; Wrobleski SK; Myers DD; Henke PK; Lawrence DA; Wakefield TW
J Vasc Surg; 2012 Mar; 55(3):815-22. PubMed ID: 22119245
[TBL] [Abstract][Full Text] [Related]
12. Acute experimental venous thrombosis impairs venous relaxation but not contraction.
Metz AK; Luke CE; Dowling A; Henke PK
J Vasc Surg; 2020 Mar; 71(3):1006-1012.e1. PubMed ID: 31248758
[TBL] [Abstract][Full Text] [Related]
13. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis.
Henke PK; Varma MR; Moaveni DK; Dewyer NA; Moore AJ; Lynch EM; Longo C; Deatrick CB; Kunkel SL; Upchurch GR; Wakefield TW
Thromb Haemost; 2007 Nov; 98(5):1045-55. PubMed ID: 18000610
[TBL] [Abstract][Full Text] [Related]
14. Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.
Dewyer NA; Sood V; Lynch EM; Luke CE; Upchurch GR; Wakefield TW; Kunkel S; Henke PK
J Surg Res; 2007 Oct; 142(2):357-63. PubMed ID: 17574586
[TBL] [Abstract][Full Text] [Related]
15. Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actions.
Obi AT; Sharma SB; Elfline MA; Luke CE; Dowling AR; Cai Q; Kimball AS; Hollinstat M; Stanger L; Moore BB; Jaffer FA; Henke PK
Sci Rep; 2023 Feb; 13(1):3253. PubMed ID: 36828892
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.
Obi AT; Diaz JA; Ballard-Lipka NL; Roelofs KJ; Farris DM; Lawrence DA; Wakefield TW; Henke PK
J Thromb Haemost; 2014 Aug; 12(8):1353-63. PubMed ID: 24943740
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of matrix metalloproteinase axis-induced neointimal growth.
Guo L; Ning W; Tan Z; Gong Z; Li X
J Mol Cell Cardiol; 2014 Jan; 66():116-25. PubMed ID: 24291441
[TBL] [Abstract][Full Text] [Related]
18. Intravenous release of NO from lipidic microbubbles accelerates deep vein thrombosis resolution in a rat model.
Wang C; Yang F; Xu Z; Shi D; Chen D; Dai J; Gu N; Jiang Q
Thromb Res; 2013 Jan; 131(1):e31-8. PubMed ID: 23199547
[TBL] [Abstract][Full Text] [Related]
19. Alterations in macrophage phenotypes in experimental venous thrombosis.
Gallagher KA; Obi AT; Elfline MA; Hogikyan E; Luke CE; Henke S; Coleman D; Henke PK
J Vasc Surg Venous Lymphat Disord; 2016 Oct; 4(4):463-71. PubMed ID: 27639001
[TBL] [Abstract][Full Text] [Related]
20. P-selectin inhibition decreases post-thrombotic vein wall fibrosis in a rat model.
Thanaporn P; Myers DD; Wrobleski SK; Hawley AE; Farris DM; Wakefield TW; Henke PK
Surgery; 2003 Aug; 134(2):365-71. PubMed ID: 12947342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
